Home › Funds › Yiheng Capital Management, L.P. › BEAM

Yiheng Capital Management, L.P. position in BEAM

BEAM THERAPEUTICS INC · Health Care

Yiheng Capital Management, L.P. reported holding 21,126 shares of BEAM (BEAM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$725K, representing 0.33% of its reported portfolio and ranking #23 among its reported holdings. Yiheng Capital Management, L.P. has disclosed BEAM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)21.13K sh
Reported value held$725.04K
Portfolio Weight0.33%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Yiheng Capital Management, L.P.'s BEAM position evolved

Yiheng Capital Management, L.P. first disclosed a stake in BEAM in Q3 2023 at 560,500 shares (US$13.5M). The position peaked in Q1 2024 at 845,500 shares, worth US$27.9M. Across 12 filings, Yiheng Capital Management, L.P. increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 21,126 shares valued at US$725K. Notable position changes include a 51% increase in Q4 2023 (shares rose 22% over the following quarter), a 84% trim in Q1 2025 (shares fell 12% over the following quarter), a 69% trim in Q4 2025 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 560.50K $13.48M New
Q4 2023 845.50K $23.01M Add
Q1 2024 845.50K $27.94M Hold
Q2 2024 845.50K $19.81M Hold
Q3 2024 763.76K $18.71M Reduce
Q4 2024 426.10K $10.57M Reduce
Q1 2025 69.06K $1.35M Reduce
Q2 2025 69.06K $1.17M Hold
Q3 2025 69.06K $1.68M Hold
Q4 2025 21.13K $585.61K Reduce
Q1 2026 21.13K $503.43K Hold
Q2 2026 21.13K $725.04K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BEAM and 13F data

BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$351.3M), ARK Invest (US$351.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BEAM

All BEAM fund holders →

FAQ

How long has Yiheng Capital Management, L.P. held BEAM?

Yiheng Capital Management, L.P. has disclosed BEAM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Yiheng Capital Management, L.P.'s current position in BEAM?

As of Q2 2026, Yiheng Capital Management, L.P. holds 21.13K shares of BEAM (BEAM THERAPEUTICS INC), valued at $725.04K, representing 0.33% of its reported portfolio and ranking #23.

Has Yiheng Capital Management, L.P. been buying or selling BEAM?

In the latest 13F filing (Q2 2026), Yiheng Capital Management, L.P. held unchanged its position in BEAM. The position peaked in Q1 2024 at 845.50K shares.

Which other funds hold BEAM?

Other major institutional holders of BEAM include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ARK Invest, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.